French Renewable Energy Stock News

Planisware SAS (ENXTPA:PLNW) shares have held steady over the past day, continuing a trend that investors have seen this month. The stock is up 2% over the past week and about 1% for the month. See our latest analysis for Planisware SAS. While Planisware SAS has shown some recent momentum with an 11.98% share price return over the past 90 days, its year-to-date share price return is still down 26.36%. Over the longer haul, the one-year total shareholder return stands at -10.74%, which...

On October 31, 2025, DM announced a partnership with VusionGroup to implement the EdgeSense digital shelf platform across approximately 70 stores, with around 20 stores already activated. This rollout leverages advanced IoT, computer vision, and AI capabilities to reduce operational complexity and improve both employee workflows and the customer experience in DM stores. We'll explore how the EdgeSense partnership supports VusionGroup’s strategy of driving retail digital transformation...

In recent weeks, European markets have experienced a pullback, with the pan-European STOXX Europe 600 Index closing lower amid concerns over artificial intelligence-related stock valuations. As investors navigate these fluctuating conditions, identifying stocks that might be trading below their estimated value can present opportunities for those seeking to capitalize on potential market inefficiencies.

As European markets face a pullback with the pan-European STOXX Europe 600 Index ending 1.24% lower due to concerns over AI-related stock valuations, investors are increasingly looking for stability amid fluctuating sentiment. In such an environment, dividend stocks can provide consistent income and potential resilience against market volatility, making them attractive options for enhancing portfolio stability.

Argan (ENXTPA:ARG) has just completed a 9,000 sq.m logistics facility in Vendin-le-Vieil, securing a 12-year lease with a major international logistics group. This project combines operational scale with a focus on sustainability. See our latest analysis for Argan. Following this milestone in Vendin-le-Vieil, Argan’s momentum has been steady this year. The stock’s share price return year-to-date sits at a solid 10.31%. Over the past year, total shareholder return reached 4.26%, signaling...

Claranova SE ( EPA:CLA ) shares have had a horrible month, losing 26% after a relatively good period beforehand...

Key Insights The projected fair value for Sopra Steria Group is €252 based on 2 Stage Free Cash Flow to Equity Sopra...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider FDJ...

With its stock down 27% over the past three months, it is easy to disregard Logic Instrument (EPA:ALLOG). However...

With a median price-to-sales (or "P/S") ratio of close to 0.3x in the Electronic industry in France, you could be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Wendel...

Earlier this month, Point One Navigation announced a new partnership with TOTEM and Orange to accelerate the rollout of Europe’s largest GNSS correction network, leveraging Orange’s advanced connectivity and TOTEM’s extensive telecom infrastructure across France and Spain. The collaboration will see Orange not only providing connectivity solutions but also acting as a commercial channel partner, expanding Orange’s involvement in both the technology and distribution of precision location...

Exail Technologies was recently added to the Euronext 150 Index, joining a select group of companies tracked by this influential benchmark. This inclusion may enhance Exail Technologies’ visibility in the investment community, particularly among institutional investors who often track major indices. We’ll explore how the company’s entry into the Euronext 150 Index could shape its investment narrative and appeal to a broader investor base. These 13 companies survived and thrived after COVID...

On October 31, 2025, OVH Groupe S.A. was removed from the Euronext 150 Index, impacting its standing among major publicly traded companies in Europe. This removal can prompt institutional investors and index-tracking funds to adjust their holdings, often influencing trading volumes and investor perception. We’ll explore how OVH Groupe’s removal from the Euronext 150 Index could affect its broader investment narrative and institutional appeal. These 13 companies survived and thrived after...

On October 30, 2025, ERAMET S.A. announced an updated production outlook, lowering its 2025 manganese ore transported volume guidance to between 6.1 and 6.3 million tonnes, down from the previous estimate of 6.5 to 7.0 million tonnes, while leaving guidance for nickel ore, lithium carbonate, and mineral sands unchanged. This revision highlights that ERAMET anticipates challenges specific to manganese operations, even as its forecasts for other commodities remain stable. We'll examine what...

In recent days, BNP Paribas announced several senior leadership appointments in the UK and Middle East, while also deploying generative AI to enhance ESG reporting efficiency across its operations. This combination of executive expansion and technology integration signals a concerted push to grow BNP Paribas's presence in priority markets and streamline its services for institutional clients. We'll examine how the strengthening of BNP Paribas's alternative investments leadership supports...

Teleperformance (ENXTPA:TEP) has revised its earnings guidance for 2025, now projecting group like-for-like revenue growth between 1% and 2% for the year. This is a change from its earlier range of 2% to 4%. This update is drawing attention from investors as expectations for growth are recalibrated. See our latest analysis for Teleperformance. The lowered revenue guidance has weighed on Teleperformance’s momentum, with the stock’s 1-year total shareholder return sitting at -30.35% and a...

The European market has recently experienced a pullback, with the pan-European STOXX Europe 600 Index ending 1.24% lower amid concerns about overvaluation in artificial intelligence-related stocks. Despite these challenges, the search for promising investment opportunities continues, particularly among smaller companies that might not be on every investor's radar. While the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant growth potential...

JCDecaux SE recently announced its third quarter 2025 sales, reporting €926.1 million in revenue, compared to €948.2 million during the same period last year, and €2.79 billion for the first nine months of 2025. This sales update gives investors a detailed view of recent operational performance, highlighting trends in the company's revenue momentum throughout the year. We'll explore how the recent quarterly sales figures may influence JCDecaux's future revenue expectations and core...

Ayvens (ENXTPA:AYV) sparked market attention after announcing a special interim dividend of EUR 0.42 per share. This represents a significant one-off payout pending shareholder approval. The company also reported a board member’s resignation. See our latest analysis for Ayvens. Ayvens has been powering ahead, with its 1-year total shareholder return of 77.05% far outpacing the share price’s already impressive 68.65% year-to-date climb. The jump in recent months appears to be driven by upbeat...

The Valeo SE ( EPA:FR ) share price has done very well over the last month, posting an excellent gain of 26%. Looking...

Key Insights Cerinnov Group's estimated fair value is €0.24 based on 2 Stage Free Cash Flow to Equity With €0.25 share...

On October 31, Nanobiotix announced it had entered a royalty-based financing agreement with HealthCare Royalty to secure up to US$71 million in non-dilutive capital, supporting its operations and the advancement of nanotherapeutic platforms. This agreement signals a reinforced financial position for Nanobiotix, potentially underpinning its ability to sustain research and development initiatives over the long term. We’ll explore how this infusion of non-dilutive capital from the royalty-based...

Recently, Ipsen presented late-breaking data from the ELATIVE trial at the AASLD Liver Meeting 2025 in Washington, revealing that IQIRVO® showed sustained biochemical response, stabilization of fibrosis markers, and notable symptom improvements over more than three years in primary biliary cholangitis patients. Further analysis indicated that IQIRVO may influence fatigue-related mitochondrial pathways, suggesting the treatment's potential long-term impact on disease progression and patient...